| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0002-6082-60 | 0002-6082 | HUMAN PRESCRIPTION DRUG | RETEVMO | selpercatinib | TABLET, COATED | ORAL | 20240410 | N/A | NDA | NDA218160 | Eli Lilly and Company | SELPERCATINIB | 80 mg/1 | 60 TABLET, COATED in 1 BOTTLE (0002-6082-60) |
| 0002-6120-60 | 0002-6120 | HUMAN PRESCRIPTION DRUG | RETEVMO | selpercatinib | TABLET, COATED | ORAL | 20240410 | N/A | NDA | NDA218160 | Eli Lilly and Company | SELPERCATINIB | 120 mg/1 | 60 TABLET, COATED in 1 BOTTLE (0002-6120-60) |
| 0002-5562-60 | 0002-5562 | HUMAN PRESCRIPTION DRUG | RETEVMO | selpercatinib | TABLET, COATED | ORAL | 20240410 | N/A | NDA | NDA218160 | Eli Lilly and Company | SELPERCATINIB | 160 mg/1 | 60 TABLET, COATED in 1 BOTTLE (0002-5562-60) |
| 0002-5340-60 | 0002-5340 | HUMAN PRESCRIPTION DRUG | RETEVMO | selpercatinib | TABLET, COATED | ORAL | 20240410 | N/A | NDA | NDA218160 | Eli Lilly and Company | SELPERCATINIB | 40 mg/1 | 60 TABLET, COATED in 1 BOTTLE (0002-5340-60) |